Liquidia Corporation, a biopharmaceutical company (NASDAQ: LQDA) located in Morrisville, North Carolina, recently announced that Michael Kaseta, the company’s Chief Operating Officer and Chief Financial Officer, will be speaking at the BofA Securities Health Care Conference 2024 in Las Vegas, Nevada on May 14, 2024. The fireside chat will begin at 5:00 p.m. PT and will provide an update on the company’s business.
Liquidia Corporation is focused on developing and commercializing products in pulmonary hypertension and other applications using its PRINT® Technology. The company operates through two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Additionally, Liquidia Technologies is working on L606, a liposomal formulation of treprostinil for use in North America.
Liquidia PAH specializes in the commercialization of pharmaceutical products to treat pulmonary diseases. They provide products such as generic Treprostinil Injection. For more information about Liquidia Corporation and their products, please visit www.liquidia.com
In South Africa, a killer whale was found to have torn apart a great white…
Elly Schlein, the leader of the Democratic Party, is calling for a new phase within…
Juventus, the Turin team, has officially joined Meta messaging service to enhance its social offering.…
Iowa has been making progress in implementing the 988 crisis line for individuals experiencing mental…
In the first five months of this year, social security benefits in Argentina, including the…
The New Popular Front, a coalition of several left-wing parties, has been formed in France…